AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2016
Dec 14, 2016
32254_dirs_2016-12-14_efdf536a-ed8c-4d5c-8914-f5a27ee57df4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2016-12-12
Reporting Person: Godshall Douglas Evan (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-12 | Employee Stock Option (right to buy) | $3.49 | A | 20000 | Acquired | 2026-07-21 | Common Stock (20000) | Direct |
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Investor Presentation
2026
Apr 13
Director's Dealing
2026
Mar 24
Legal Proceedings Report
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7